Cargando…
Association of TP53 clonal hematopoiesis with indeterminate potential with the development of myeloid neoplasms after rucaparib treatment
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816858/ https://www.ncbi.nlm.nih.gov/pubmed/36618808 http://dx.doi.org/10.21037/atm-2022-65 |
| _version_ | 1784864634579189760 |
|---|---|
| author | Yoshida, Reiko Nakamura, Seigo |
| author_facet | Yoshida, Reiko Nakamura, Seigo |
| author_sort | Yoshida, Reiko |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9816858 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98168582023-01-07 Association of TP53 clonal hematopoiesis with indeterminate potential with the development of myeloid neoplasms after rucaparib treatment Yoshida, Reiko Nakamura, Seigo Ann Transl Med Editorial Commentary AME Publishing Company 2022-12 /pmc/articles/PMC9816858/ /pubmed/36618808 http://dx.doi.org/10.21037/atm-2022-65 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Yoshida, Reiko Nakamura, Seigo Association of TP53 clonal hematopoiesis with indeterminate potential with the development of myeloid neoplasms after rucaparib treatment |
| title | Association of TP53 clonal hematopoiesis with indeterminate potential with the development of myeloid neoplasms after rucaparib treatment |
| title_full | Association of TP53 clonal hematopoiesis with indeterminate potential with the development of myeloid neoplasms after rucaparib treatment |
| title_fullStr | Association of TP53 clonal hematopoiesis with indeterminate potential with the development of myeloid neoplasms after rucaparib treatment |
| title_full_unstemmed | Association of TP53 clonal hematopoiesis with indeterminate potential with the development of myeloid neoplasms after rucaparib treatment |
| title_short | Association of TP53 clonal hematopoiesis with indeterminate potential with the development of myeloid neoplasms after rucaparib treatment |
| title_sort | association of tp53 clonal hematopoiesis with indeterminate potential with the development of myeloid neoplasms after rucaparib treatment |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816858/ https://www.ncbi.nlm.nih.gov/pubmed/36618808 http://dx.doi.org/10.21037/atm-2022-65 |
| work_keys_str_mv | AT yoshidareiko associationoftp53clonalhematopoiesiswithindeterminatepotentialwiththedevelopmentofmyeloidneoplasmsafterrucaparibtreatment AT nakamuraseigo associationoftp53clonalhematopoiesiswithindeterminatepotentialwiththedevelopmentofmyeloidneoplasmsafterrucaparibtreatment |